Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Food AdditivesNutraceutical

PUBLISHER: MarketsandMarkets | PRODUCT CODE: 2109024

Cover Image

PUBLISHER: MarketsandMarkets | PRODUCT CODE: 2109024

Omega-3 Market by Type (DHA, EPA, & ALA), Source, Application (Dietary Supplements, Functional Foods & Beverages, Pharmaceuticals, Infant Formulas, and Pet Food & Feed), Form, Manufacturing Technology, and Region - Global Forecast to 2031

PUBLISHED:
PAGES: 326 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 4950
PDF (5-user License)
USD 6650
PDF (Corporate License)
USD 8150
PDF (Global License)
USD 10000

Add to Cart

Description

Table of Contents

List of Tables

The omega-3 market is estimated to be USD 4.88 billion in 2026 and is projected to reach USD 8.73 billion by 2031, at a CAGR of 12.3%.

Scope of the Report
Years Considered for the Study2022-2031
Base Year2025
Forecast Period2026-2031
Units ConsideredValue (USD) and Volume (Kiloton)
SegmentsType, Source, Application, Form, Manufacturing Technology, and Region
Regions coveredNorth America, Europe, Asia Pacific, South America, and RoW

The omega-3 market is gaining significant traction, driven by the increasing recognition of the roles of EPA and DHA in cardiovascular health, cognitive function, vision, joint health, and infant brain development, as well as a growing consumer shift toward preventive healthcare and functional nutrition. The infant formula sector has witnessed explosive growth, driven by rising awareness among parents about the importance of early nutrition for cognitive and physical development, particularly the role of DHA and other essential nutrients, and regulatory mandates and recommendations in regions such as Europe, North America, and China requiring or encouraging DHA fortification in infant formula. However, high costs involved in R&D activities and unstable fish oil prices are expected to pose a challenge to the omega-3 market's growth.

Omega-3 Market - IMG1

Disruptions in the omega-3 market may offer opportunities for players

The omega-3 market is undergoing fundamental shifts, opening up new opportunities for companies. One of the most significant changes is the shift toward sustainable and plant-based sources such as algal oil and fermentation-based omega-3, which eliminate fish oil supply concerns and resonate with vegan and green consumers. Regulatory updates, such as the mandatory fortification of DHA in infant nutrition and broader approvals for cardiovascular and cognitive well-being claims, are also driving steady demand in both developed and emerging markets. Meanwhile, technological advances such as microencapsulation are enhancing stability and flavor, allowing omega-3 to be incorporated in new food and beverage applications.

On the application front, Omega-3 is increasingly being used in pharmaceuticals, pet food, and aquaculture, apart from conventional supplements. Pharma-grade formulations for neurological and cardiovascular health are gaining momentum, while high-end pet food and fortified aquaculture feed are experiencing significant growth. Alongside growing demand for convenience formats of functional nutrition products (gummies, powders, RTDs) and increasing consumer spending on health supplement products in South America and the Asia Pacific, these trends are redefining the landscape of the market. Players who innovate in sourcing, product development, and sustainability have a good chance of securing growth in emerging markets.

The dietary supplement segment is projected to be one of the fastest-growing segments

The dietary supplement category is one of the major growth drivers for the omega-3 market as consumers place greater emphasis on preventive healthcare and turn to convenient solutions for heart, brain, eye, and joint well-being. Supported by regulatory approvals for health claims, supplements offer confidence and convenience, as advancements in delivery forms, such as softgels, gummies, and powders, make them attractive to people of all ages. This synergy of health consciousness, aging population, and product creativity is driving robust and consistent demand for omega-3 in dietary supplements.

The liquid form of omega-3 is expected to hold a larger share of the omega-3 market

The majority of commercial omega-3 comes from fish oil, algal oil, and krill oil, which are naturally liquid forms and commonly used in dietary supplements, infant formula, functional foods, and pharmaceuticals. Liquids can accommodate higher purity, greater bioavailability, and simpler inclusion in soft gels, emulsions, and fortified liquid food. While dry formulations (powders, microencapsulated omega-3) are increasing as a result of uses in gummies, powders, and bakery applications, the liquid form continues to hold a significant market share as it is the most cost-efficient, mass-produced, and immediately applicable state across industries.

The eicosapentaenoic acid (EPA) segment is expected to grow at a significant rate

The EPA has been shown to benefit heart health, including reducing triglyceride levels, decreasing inflammation, and improving overall cardiovascular function. As awareness of these health benefits increases among consumers, there is a growing demand for omega-3 supplements and fortified foods and beverages containing EPA, which contributes to the expansion of the omega-3 market.

The US is estimated to dominate the North American omega-3 market during the forecast period

The US is one of the largest global markets for omega-3. The consumption of omega-3-based products and supplements has increased significantly due to rising consumer awareness of their various health benefits and their availability in the US market. The omega-3 consumption pattern in the US is driven toward categories such as capsules, dietary supplements, and infant formula. However, the country has one of the largest consumer markets in the world. Recently, the EPA/DHA (omega-3) ingredients sector has experienced a surge in product innovations, introducing new omega-3 variants and expanding the utilization of plant-based sources. As consumers increasingly prioritize the health of oceans, there is a growing demand for plant-based omega-3 ingredients within the dietary supplement sector.

In-depth interviews have been conducted with chief executive officers (CEOs), directors, and other executives from various key organizations operating in the omega-3 market.

  • By Company Type: Tier 1 - 30%, Tier 2 - 25%, and Tier 3 - 45%
  • By Designation: CXOs - 25%, Managers - 40%, Executives - 35%
  • By Region: North America - 22%, Europe - 28%, Asia Pacific - 32%, South America - 10%, and Rest of the World - 8%

Prominent companies in the market include BASF SE (Germany), Cargill, Incorporated (US), DSM-Firmenich (Netherlands), ADM (US), Kerry Group plc (Ireland), Aker BioMarine (Norway), Croda International PLC (UK), Corbion (Netherlands), Pelagia AS (Norway), KD Pharma Group SA (Switzerland), GC Rieber (Norway), Cooke Aquaculture Inc. (Canada), GOLDEN OMEGA (Chile), Polaris (France), Btsa (Spain), KinOmega Biopharm Inc. (China), Rimfrost AS (Norway), Mara Renewables (Canada), Cellana Inc. (US), and AlgaeCytes Limited (UK).

Research Coverage

This research report categorizes the omega-3 market by type (docosahexaenoic acid (DHA), eicosapentaenoic acid (EPA), and alpha-linolenic acid (ALA)), source (marine [fish, algal, krill, and other marine sources] and plant [nuts & seeds and vegetable oils]), application (dietary supplements, functional foods & beverages, pharmaceuticals, infant formulas, and pet food and feed), form (dry and liquid), manufacturing technology (qualitative) (extraction, refining & purification, concentration & conversion, encapsulation & stabilization, and fermentation & biotechnology), and region (North America, Europe, Asia Pacific, South America, and Rest of the World).

The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of omega-3 ingredients. A thorough analysis of the key industry players has been done to provide insights into their business, services, key strategies, contracts, partnerships, agreements, product launches, mergers & acquisitions, and recent developments associated with the omega-3 market. This report covers the competitive analysis of upcoming startups in the omega-3 market ecosystem. Furthermore, the study covers industry-specific trends, including technology analysis, ecosystem & market mapping, and patent & regulatory landscapes, among others.

Reasons to Buy This Report

The report offers market leaders/new entrants information on the closest approximations of the revenue numbers for the overall omega-3 and subsegments. It will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

The report provides insights into the following pointers:

  • Analysis of key drivers (Rising adoption of algal oil and plant-based omega-3 (flaxseed, chia, canola) due to concerns over fish oil sustainability), restraints (lack of clarity among consumers about daily recommended intake and health claims), opportunities (increase in research for development of alternative sources to obtain omega-3), and challenges (highly unstable fish oil prices) influencing the growth of the omega-3 market
  • Product Development/Innovation: Detailed insights on research & development activities and new product launches in the omega-3 market
  • Market Development: Comprehensive information about lucrative markets-the report analyzes omega-3 across varied regions
  • Market Diversification: Exhaustive information about new product sources, untapped geographies, recent developments, and investments in the omega-3 market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, brand/product comparison, and product footprints of leading players such as BASF SE (Germany), Cargill, Incorporated (US), DSM-Firmenich (Netherlands), ADM (US), Kerry Group plc (Ireland), Aker BioMarine (Norway), Croda International PLC (UK), Corbion (Netherlands), Pelagia AS (Norway), KD Pharma Group SA (Switzerland), and other players in the omega-3 market
Show more
Product Code: FB 2759

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 STUDY SCOPE
    • 1.3.1 MARKETS COVERED AND REGIONS CONSIDERED
    • 1.3.2 INCLUSIONS AND EXCLUSIONS
    • 1.3.3 YEARS CONSIDERED
    • 1.3.4 CURRENCY CONSIDERED
    • 1.3.5 UNITS CONSIDERED
  • 1.4 STAKEHOLDERS
  • 1.5 SUMMARY OF CHANGES

2 EXECUTIVE SUMMARY

  • 2.1 MARKET HIGHLIGHTS AND KEY INSIGHTS
  • 2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS
  • 2.3 DISRUPTIVE TRENDS IN OMEGA-3 MARKET
  • 2.4 HIGH-GROWTH SEGMENTS
  • 2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST

3 PREMIUM INSIGHTS

  • 3.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN OMEGA-3 MARKET
  • 3.2 OMEGA-3 MARKET, BY TYPE AND REGION
  • 3.3 OMEGA-3 MARKET, BY 3 TYPES
  • 3.4 OMEGA-3 MARKET, BY SOURCE
  • 3.5 OMEGA-3 MARKET, BY FORM
  • 3.6 OMEGA-3 MARKET, BY APPLICATION
  • 3.7 OMEGA-3 MARKET, BY COUNTRY

4 MARKET OVERVIEW

  • 4.1 INTRODUCTION
  • 4.2 MARKET DYNAMICS
    • 4.2.1 DRIVERS
      • 4.2.1.1 Growing consumer awareness regarding health benefits
      • 4.2.1.2 Increasing use in food and feed products
        • 4.2.1.2.1 Rising demand for mother and infant nutrition products
        • 4.2.1.2.2 Mandatory inclusion of algal DHA in infant formula
        • 4.2.1.2.3 Growth focus of food processing companies on fortification
        • 4.2.1.2.4 Increasing applications in pet food and feed
      • 4.2.1.3 Shift toward pharmaceutical-grade high-concentrate omega-3 oils in developed markets
      • 4.2.1.4 Emergence of innovative production technologies
    • 4.2.2 RESTRAINTS
      • 4.2.2.1 Declining fish oil supply due to sustainability issues in fisheries
      • 4.2.2.2 Lack of clarity on daily intake recommendations and health claims
    • 4.2.3 OPPORTUNITIES
      • 4.2.3.1 Increasing research on alternative sources
        • 4.2.3.1.1 Rising consumer demand for plant-based products
        • 4.2.3.1.2 Growing focus on microalgae-based omega-3 production
        • 4.2.3.1.3 Side effects and allergies related to fish-based products
      • 4.2.3.2 Favorable regulatory environment
      • 4.2.3.3 Integration of microencapsulation technology
    • 4.2.4 CHALLENGES
      • 4.2.4.1 High costs involved in R&D activities
      • 4.2.4.2 Volatility in fish oil prices
      • 4.2.4.3 Instability of omega-3 oils
  • 4.3 UNMET NEEDS AND WHITE SPACES
    • 4.3.1 UNMET NEEDS IN THE OMEGA 3 MARKET
    • 4.3.2 WHITE SPACE OPPORTUNITIES
  • 4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
    • 4.4.1 INTERCONNECTED MARKETS
    • 4.4.2 CROSS SECTOR OPPORTUNITIES
  • 4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS

5 INDUSTRY TRENDS

  • 5.1 PORTER'S FIVE FORCES ANALYSIS
    • 5.1.1 INTENSITY OF COMPETITIVE RIVALRY
    • 5.1.2 BARGAINING POWER OF SUPPLIERS
    • 5.1.3 BARGAINING POWER OF BUYERS
    • 5.1.4 THREAT OF SUBSTITUTES
    • 5.1.5 THREAT OF NEW ENTRANTS
  • 5.2 MACROECONOMIC OUTLOOK
    • 5.2.1 INTRODUCTION
  • 5.3 MACROECONOMIC INDICATORS
    • 5.3.1 SUSTAINABILITY AND CIRCULAR ECONOMY INITIATIVES
    • 5.3.2 PREVENTIVE HEALTHCARE EXPENDITURE
    • 5.3.3 GROWING GERIATRIC POPULATION
  • 5.4 VALUE CHAIN ANALYSIS
    • 5.4.1 RESEARCH AND PRODUCT DEVELOPMENT
    • 5.4.2 SOURCING
    • 5.4.3 PRODUCTION AND PROCESSING
    • 5.4.4 DISTRIBUTION
    • 5.4.5 MARKETING AND SALES
    • 5.4.6 END USERS
  • 5.5 ECOSYSTEM ANALYSIS
    • 5.5.1 DEMAND SIDE
    • 5.5.2 SUPPLY SIDE
  • 5.6 PRICING ANALYSIS
    • 5.6.1 INTRODUCTION
    • 5.6.2 AVERAGE SELLING PRICE OF OMEGA-3 FINISHED PRODUCTS, BY PRODUCT TYPE
    • 5.6.3 AVERAGE SELLING PRICE (ASP) TREND, BY REGION
    • 5.6.4 AVERAGE SELLING PRICE (ASP) TREND, BY SOURCE
  • 5.7 TRADE ANALYSIS
    • 5.7.1 IMPORT ANALYSIS: OMEGA-3
    • 5.7.2 EXPORT ANALYSIS: OMEGA-3
  • 5.8 KEY CONFERENCES AND EVENTS, 2026-2027
  • 5.9 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • 5.10 INVESTMENT AND FUNDING SCENARIO
  • 5.11 CASE STUDY ANALYSIS
    • 5.11.1 MIALGAE INTRODUCED SUSTAINABLE OMEGA-3 PRODUCTION WITH INNOVATIVE BIOTECHNOLOGY
    • 5.11.2 KD PHARMA GROUP: ADVANCING PHARMACEUTICAL-GRADE OMEGA-3 PURIFICATION TECHNOLOGIES
    • 5.11.3 VERAMARIS: PIONEERING SUSTAINABLE OMEGA-3 SOLUTIONS IN AQUACULTURE
    • 5.11.4 DSM-FIRMENICH: EXPANDING ALGAE-DERIVED DHA ACROSS LIFE-STAGE NUTRITION
    • 5.11.5 AKER BIOMARINE EXPANDED EUROPEAN MARKET ACCESS THROUGH STRATEGIC DISTRIBUTION PARTNERSHIPS
  • 5.12 IMPACT OF 2025 US TARIFFS - OMEGA-3 MARKET
    • 5.12.1 INTRODUCTION
    • 5.12.2 PRICE IMPACT ANALYSIS
    • 5.12.3 IMPACT ON COUNTRIES/REGIONS
      • 5.12.3.1 US
      • 5.12.3.2 Europe
      • 5.12.3.3 Asia Pacific
    • 5.12.4 IMPACT ON END-USE INDUSTRIES

6 TECHNOLOGY ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS

  • 6.1 TECHNOLOGY ANALYSIS
    • 6.1.1 KEY TECHNOLOGIES
      • 6.1.1.1 Molecular distillation
      • 6.1.1.2 Supercritical CO2 extraction
      • 6.1.1.3 Algae fermentation
    • 6.1.2 COMPLEMENTARY TECHNOLOGIES
      • 6.1.2.1 Stabilization & antioxidant technologies
      • 6.1.2.2 Microencapsulation
    • 6.1.3 ADJACENT TECHNOLOGIES
      • 6.1.3.1 Precision fermentation
      • 6.1.3.2 Synthetic biology & bioprocess engineering
    • 6.1.4 TECHNOLOGY/PRODUCT ROADMAP
      • 6.1.4.1 Short-Term | High-Purity Omega-3 Production & Stability Enhancement
      • 6.1.4.2 Mid-Term | Sustainable EPA & DHA Manufacturing
      • 6.1.4.3 Long-Term | Precision Nutrition & Next-Generation Omega-3 Innovation
  • 6.2 PATENT ANALYSIS
  • 6.3 FUTURE APPLICATIONS
    • 6.3.1 CLINICAL NUTRITION & HEALTHY AGING: EXPANDING THE FUTURE OF OMEGA-3 APPLICATIONS
    • 6.3.2 STABLE DHA-ENRICHED FUNCTIONAL FOODS: ADVANCING THE NEXT GENERATION OF OMEGA-3 NUTRITION
    • 6.3.3 PLANT-BASED OMEGA-3 SUPPLEMENTATION: ENABLING THE FUTURE OF PERSONALIZED VEGAN NUTRITION
    • 6.3.4 OMEGA-3 BIOMARKER-BASED PRENATAL NUTRITION: ENABLING PRECISION MATERNAL HEALTHCARE
  • 6.4 IMPACT OF GENERATIVE AI ON OMEGA 3 MARKET
    • 6.4.1 INTRODUCTION
    • 6.4.2 TOP USE CASES AND MARKET POTENTIAL
    • 6.4.3 BEST PRACTICES IN OMEGA 3 INDUSTRY
    • 6.4.4 CASE STUDIES OF AI IMPLEMENTATION IN OMEGA 3 MARKET
    • 6.4.5 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS
    • 6.4.6 CLIENTS' READINESS TO ADOPT GENERATIVE AI FOR OMEGA 3 PRODUCTION
  • 6.5 SUCCESS STORIES AND REAL-WORLD APPLICATIONS

7 SUSTAINABILITY AND REGULATORY LANDSCAPE

  • 7.1 REGIONAL REGULATIONS AND COMPLIANCE
    • 7.1.1 INDUSTRY STANDARDS
    • 7.1.2 LABELING REQUIREMENTS AND CLAIMS
    • 7.1.3 ANTICIPATED REGULATORY CHANGES IN NEXT 5-10 YEARS
      • 7.1.3.1 Enhanced Traceability and Sustainability Requirements
      • 7.1.3.2 Global Harmonization of Omega-3 Labeling and Health Claims
      • 7.1.3.3 Stricter Quality, Purity, and Contaminant Standards
      • 7.1.3.4 Digital Traceability, AI-Enabled Quality Monitoring, and Compliance Automation
      • 7.1.3.5 Stronger Sustainability and ESG Compliance Requirements
  • 7.2 SUSTAINABILITY INITIATIVES
    • 7.2.1 SUSTAINABLE SOURCING
    • 7.2.2 CARBON FOOTPRINT REDUCTION INITIATIVES
    • 7.2.3 CIRCULAR ECONOMY APPROACHES
  • 7.3 SUSTAINABILITY IMPACT AND REGULATORY POLICY INITIATIVES
  • 7.4 CERTIFICATIONS, LABELING, ECO-STANDARDS

8 CUSTOMER LANDSCAPE AND BUYER BEHAVIOR

  • 8.1 DECISION-MAKING PROCESS
  • 8.2 KEY STAKEHOLDERS AND BUYING CRITERIA
    • 8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 8.2.2 BUYING CRITERIA
  • 8.3 ADOPTION BARRIERS AND INTERNAL CHALLENGES
  • 8.4 UNMET NEEDS OF VARIOUS APPLICATION INDUSTRIES ACROSS SUPPLY CHAIN
  • 8.5 MARKET PROFITABILITY
  • 8.6 REVENUE POTENTIAL
    • 8.6.1 COST DYNAMICS

9 OMEGA-3 MARKET, BY TYPE

  • 9.1 INTRODUCTION
  • 9.2 DOCOSAHEXAENOIC ACID
    • 9.2.1 NEED FOR PROTECTION AGAINST ALZHEIMER'S DISEASE TO DRIVE DEMAND
  • 9.3 EICOSAPENTAENOIC ACID
    • 9.3.1 ABILITY TO REDUCE SUSCEPTIBILITY TO CARDIOVASCULAR DISEASES TO BOOST DEMAND
  • 9.4 ALPHA-LINOLENIC ACID
    • 9.4.1 GROWING POPULARITY AMONG VEGETARIANS AND VEGANS TO BOOST DEMAND

10 OMEGA-3 MARKET, BY SOURCE

  • 10.1 INTRODUCTION
  • 10.2 MARINE
    • 10.2.1 NEED FOR HEALTHY FETAL DEVELOPMENT IN PREGNANT WOMEN TO DRIVE MARKET
    • 10.2.2 FISH
      • 10.2.2.1 Anchovy
      • 10.2.2.2 Sardine
      • 10.2.2.3 Mackerel
      • 10.2.2.4 Other fish types
    • 10.2.3 ALGAE
      • 10.2.3.1 Schizochytrium sp.
      • 10.2.3.2 Crypthecodinium cohnii
      • 10.2.3.3 Nannochloropsis sp.
      • 10.2.3.4 Other algae types
    • 10.2.4 KRILL
    • 10.2.5 OTHER MARINE SOURCES
  • 10.3 PLANT
    • 10.3.1 GROWING USE OF FLAX SEEDS FOR CANCER PREVENTION TO BOOST DEMAND
    • 10.3.2 NUTS & SEEDS
    • 10.3.3 VEGETABLE OILS

11 OMEGA-3 MARKET, BY APPLICATION

  • 11.1 INTRODUCTION
  • 11.2 DIETARY SUPPLEMENTS
    • 11.2.1 GROWING IMPORTANCE OF BALANCED AND NUTRITIOUS DIETS TO DRIVE DEMAND
  • 11.3 FUNCTIONAL FOODS & BEVERAGES
    • 11.3.1 ABILITY TO BOOST CARDIOVASCULAR HEALTH TO DRIVE DEMAND
    • 11.3.2 DAIRY & DAIRY ALTERNATIVES
    • 11.3.3 BAKERY & CEREAL PRODUCTS
    • 11.3.4 CONFECTIONERY PRODUCTS
    • 11.3.5 MEAT & MEAT PRODUCTS
    • 11.3.6 BEVERAGES
    • 11.3.7 OTHER FUNCTIONAL FOOD PRODUCTS
  • 11.4 PHARMACEUTICALS
    • 11.4.1 GROWING NEED TO LOWER ELEVATED TRIGLYCERIDE LEVELS TO DRIVE MARKET
  • 11.5 INFANT FORMULAS
    • 11.5.1 RISING CONSUMPTION OF OMEGA-3 DHA DURING PREGNANCY TO BOOST DEMAND
  • 11.6 PET FOOD & FEED
    • 11.6.1 GREATER EMPHASIS ON ENHANCING IMMUNITY IN PETS TO DRIVE MARKET
    • 11.6.2 PET FOOD
    • 11.6.3 ANIMAL FEED

12 OMEGA-3 MARKET, BY FORM

  • 12.1 INTRODUCTION
  • 12.2 DRY
    • 12.2.1 ENCAPSULATED STABILITY MEETS VERSATILE APPLICATIONS
  • 12.3 LIQUID
    • 12.3.1 HIGH BIOAVAILABILITY AND EFFICACY TO FUEL DEMAND

13 OMEGA 3 MARKET, BY MANUFACTURING TECHNOLOGY

  • 13.1 INTRODUCTION
  • 13.2 EXTRACTION
  • 13.3 REFINING & PURIFICATION
  • 13.4 CONCENTRATION & CONVERSION
  • 13.5 ENCAPSULATION & STABILIZATION
  • 13.6 FERMENTATION & BIOTECHNOLOGY

14 OMEGA-3 MARKET, BY REGION

  • 14.1 INTRODUCTION
  • 14.2 NORTH AMERICA
    • 14.2.1 US
      • 14.2.1.1 Growing incorporation of omega-3 in dietary supplements to drive market
    • 14.2.2 CANADA
      • 14.2.2.1 Increasing application in functional foods & beverages to boost market
    • 14.2.3 MEXICO
      • 14.2.3.1 Growing focus on heart disease prevention to drive market
  • 14.3 EUROPE
    • 14.3.1 GERMANY
      • 14.3.1.1 Low fish consumption to boost demand for omega-3-based supplements
    • 14.3.2 UK
      • 14.3.2.1 Rising gastrointestinal health awareness supporting Omega-3 demand
    • 14.3.3 FRANCE
      • 14.3.3.1 Rising cardiovascular disease burden driving Omega-3 consumption
    • 14.3.4 NORWAY
      • 14.3.4.1 Production of genetically modified canola to offer lucrative growth opportunities to market players
    • 14.3.5 ITALY
      • 14.3.5.1 High production of dietary supplements, functional food products, and beverages to boost market
    • 14.3.6 SPAIN
      • 14.3.6.1 Rising consumer awareness and dietary gaps to drive market
    • 14.3.7 NETHERLANDS
      • 14.3.7.1 Growing incidences of depression, autism, and ADHD to drive market
    • 14.3.8 REST OF EUROPE
  • 14.4 ASIA PACIFIC
    • 14.4.1 CHINA
      • 14.4.1.1 Increasing focus on product innovations and diversification to drive market
    • 14.4.2 INDIA
      • 14.4.2.1 Growing incidences of heart failure to drive market
    • 14.4.3 JAPAN
      • 14.4.3.1 Rapidly aging population driving demand for Omega-3 supplements
    • 14.4.4 AUSTRALIA & NEW ZEALAND
      • 14.4.4.1 Government-led initiatives to increase awareness regarding omega-3 to drive market
    • 14.4.5 REST OF ASIA PACIFIC
  • 14.5 SOUTH AMERICA
    • 14.5.1 BRAZIL
      • 14.5.1.1 Rising demand for algal oils to drive market
    • 14.5.2 ARGENTINA
      • 14.5.2.1 Commercialization of omega-3 products to fuel market
    • 14.5.3 REST OF SOUTH AMERICA
  • 14.6 REST OF THE WORLD (ROW)
    • 14.6.1 AFRICA
      • 14.6.1.1 Prevalence of undernutrition among pregnant women and children to drive market
    • 14.6.2 MIDDLE EAST
      • 14.6.2.1 Ongoing innovations in omega-3 products to drive market

15 COMPETITIVE LANDSCAPE

  • 15.1 OVERVIEW
  • 15.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
  • 15.3 REVENUE ANALYSIS
  • 15.4 MARKET SHARE ANALYSIS
  • 15.5 COMPANY VALUATION AND FINANCIAL METRICS
  • 15.6 OMEGA-3 MARKET: BRAND/PRODUCT COMPARISON
  • 15.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
    • 15.7.1 STARS
    • 15.7.2 EMERGING LEADERS
    • 15.7.3 PERVASIVE PLAYERS
    • 15.7.4 PARTICIPANTS
    • 15.7.5 COMPANY FOOTPRINT: KEY PLAYERS
      • 15.7.5.1 Company footprint
      • 15.7.5.2 Regional footprint
      • 15.7.5.3 Source footprint
      • 15.7.5.4 Type footprint
      • 15.7.5.5 Application footprint
  • 15.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
    • 15.8.1 PROGRESSIVE COMPANIES
    • 15.8.2 RESPONSIVE COMPANIES
    • 15.8.3 DYNAMIC COMPANIES
    • 15.8.4 STARTING BLOCKS
    • 15.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
  • 15.9 COMPETITIVE SCENARIO AND TRENDS
    • 15.9.1 OMEGA-3 MARKET: PRODUCT LAUNCHES
    • 15.9.2 DEALS
    • 15.9.3 EXPANSIONS

16 COMPANY PROFILES

  • 16.1 KEY PLAYERS
    • 16.1.1 DSM-FIRMENICH
      • 16.1.1.1 Business overview
      • 16.1.1.2 Products/Solutions/Services offered
      • 16.1.1.3 Recent developments
        • 16.1.1.3.1 Product launches and enhancements
      • 16.1.1.4 MnM view
        • 16.1.1.4.1 Key strengths
        • 16.1.1.4.2 Strategic choices
        • 16.1.1.4.3 Weaknesses and competitive threats
    • 16.1.2 CARGILL, INCORPORATED
      • 16.1.2.1 Business overview
      • 16.1.2.2 Products/Solutions/Services offered
      • 16.1.2.3 Recent developments
        • 16.1.2.3.1 Deals
      • 16.1.2.4 MnM view
        • 16.1.2.4.1 Key strengths
        • 16.1.2.4.2 Strategic choices
        • 16.1.2.4.3 Weaknesses and competitive threats
    • 16.1.3 BASF SE
      • 16.1.3.1 Business overview
      • 16.1.3.2 Products/Solutions/Services offered
      • 16.1.3.3 Recent developments
        • 16.1.3.3.1 Deals
      • 16.1.3.4 MnM view
        • 16.1.3.4.1 Key strengths
        • 16.1.3.4.2 Strategic choices
        • 16.1.3.4.3 Weaknesses and competitive threats
    • 16.1.4 ADM
      • 16.1.4.1 Business overview
      • 16.1.4.2 Products/Solutions/Services offered
      • 16.1.4.3 MnM view
        • 16.1.4.3.1 Key strengths
        • 16.1.4.3.2 Strategic choices
        • 16.1.4.3.3 Weaknesses and competitive threats
    • 16.1.5 KERRY GROUP PLC
      • 16.1.5.1 Business overview
      • 16.1.5.2 Products/Solutions/Services offered
      • 16.1.5.3 Recent developments
        • 16.1.5.3.1 Deals
      • 16.1.5.4 MnM view
        • 16.1.5.4.1 Key strengths
        • 16.1.5.4.2 Strategic choices
        • 16.1.5.4.3 Weaknesses and competitive threats
    • 16.1.6 CORBION
      • 16.1.6.1 Business overview
      • 16.1.6.2 Products/Solutions/Services offered
      • 16.1.6.3 Recent developments
        • 16.1.6.3.1 Product launches and enhancements
        • 16.1.6.3.2 Other developments
      • 16.1.6.4 MnM view
    • 16.1.7 KD PHARMA GROUP SA
      • 16.1.7.1 Business overview
      • 16.1.7.2 Products/Solutions/Services offered
      • 16.1.7.3 Recent developments
        • 16.1.7.3.1 Deals
        • 16.1.7.3.2 Expansions
      • 16.1.7.4 MnM view
    • 16.1.8 AKER BIOMARINE
      • 16.1.8.1 Business overview
      • 16.1.8.2 Products/Solutions/Services offered
      • 16.1.8.3 Recent developments
        • 16.1.8.3.1 Product launches and enhancements
        • 16.1.8.3.2 Expansions
        • 16.1.8.3.3 Deals
        • 16.1.8.3.4 Other developments
      • 16.1.8.4 MnM view
    • 16.1.9 CRODA INTERNATIONAL PLC
      • 16.1.9.1 Business overview
      • 16.1.9.2 Products/Solutions/Services offered
      • 16.1.9.3 MnM view
    • 16.1.10 EVONIK INDUSTRIES AG
      • 16.1.10.1 Business overview
      • 16.1.10.2 Products/Solutions/Services offered
      • 16.1.10.3 Recent developments
        • 16.1.10.3.1 Deals
      • 16.1.10.4 MnM view
    • 16.1.11 PELAGIA
      • 16.1.11.1 Business overview
      • 16.1.11.2 Products/Solutions/Services offered
      • 16.1.11.3 Recent developments
        • 16.1.11.3.1 Product launches and enhancements
        • 16.1.11.3.2 Other developments
      • 16.1.11.4 MnM view
    • 16.1.12 GC RIEBER
      • 16.1.12.1 Business overview
      • 16.1.12.2 Products/Solutions/Services offered
      • 16.1.12.3 Recent developments
        • 16.1.12.3.1 Product launches and enhancements
        • 16.1.12.3.2 Expansions
      • 16.1.12.4 MnM view
    • 16.1.13 COOKE AQUACULTURE INC.
      • 16.1.13.1 Business overview
      • 16.1.13.2 Products/Solutions/Services offered
      • 16.1.13.3 Recent developments
        • 16.1.13.3.1 Deals
      • 16.1.13.4 MnM view
    • 16.1.14 ALGISYS BIOSCIENCES, INC.
      • 16.1.14.1 Business overview
      • 16.1.14.2 Products/Solutions/Services offered
      • 16.1.14.3 Recent developments
        • 16.1.14.3.1 Other developments
      • 16.1.14.4 MnM view
    • 16.1.15 POLARIS
      • 16.1.15.1 Business overview
      • 16.1.15.2 Products/Solutions/Services offered
      • 16.1.15.3 Recent developments
        • 16.1.15.3.1 Product launches and enhancements
        • 16.1.15.3.2 Other developments
      • 16.1.15.4 MnM view
  • 16.2 OTHER PLAYERS
    • 16.2.1 BTSA
      • 16.2.1.1 Business overview
      • 16.2.1.2 Products/Solutions/Services offered
      • 16.2.1.3 MnM view
    • 16.2.2 NOVOSANA EUROPE B.V.
      • 16.2.2.1 Business overview
      • 16.2.2.2 Products/Solutions/Services offered
      • 16.2.2.3 MnM view
    • 16.2.3 GOLDEN OMEGA
      • 16.2.3.1 Business overview
      • 16.2.3.2 Products/Solutions/Services offered
      • 16.2.3.3 Recent developments
        • 16.2.3.3.1 Deals
      • 16.2.3.4 MnM view
    • 16.2.4 KINOMEGA BIOPHARM INC.
      • 16.2.4.1 Business overview
      • 16.2.4.2 Products/Solutions/Services offered
      • 16.2.4.3 MnM view
    • 16.2.5 RIMFROST AS
      • 16.2.5.1 Business overview
      • 16.2.5.2 Products/Solutions/Services offered
      • 16.2.5.3 Recent developments
        • 16.2.5.3.1 Deals
      • 16.2.5.4 MnM view
    • 16.2.6 ALGARITHM
    • 16.2.7 SOLUTEX
    • 16.2.8 CELLANA INC.
    • 16.2.9 SINOMEGA BIOTECH ENGINEERING CO., LTD.
    • 16.2.10 ALGAECYTES LIMITED

17 RESEARCH METHODOLOGY

  • 17.1 RESEARCH DATA
    • 17.1.1 SECONDARY DATA
      • 17.1.1.1 Key data from secondary sources
    • 17.1.2 PRIMARY DATA
      • 17.1.2.1 Key data from primary sources
      • 17.1.2.2 Breakdown of primary profiles
      • 17.1.2.3 Key insights from industry experts
  • 17.2 MARKET SIZE ESTIMATION
    • 17.2.1 TOP-DOWN APPROACH
    • 17.2.2 SUPPLY-SIDE ANALYSIS
    • 17.2.3 BOTTOM-UP APPROACH (DEMAND SIDE)
  • 17.3 DATA TRIANGULATION AND MARKET BREAKUP
  • 17.4 RESEARCH ASSUMPTIONS
  • 17.5 RESEARCH LIMITATIONS AND RISK ASSESSMENT

18 ADJACENT & RELATED MARKETS

  • 18.1 INTRODUCTION
  • 18.2 STUDY LIMITATIONS
  • 18.3 FUNCTIONAL FOOD INGREDIENTS MARKET
    • 18.3.1 MARKET DEFINITION
    • 18.3.2 MARKET OVERVIEW
  • 18.4 MARINE COLLAGEN MARKET
    • 18.4.1 MARKET DEFINITION
    • 18.4.2 MARKET OVERVIEW

19 APPENDIX

  • 19.1 DISCUSSION GUIDE
  • 19.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 19.3 CUSTOMIZATION OPTIONS
  • 19.4 RELATED REPORTS
  • 19.5 AUTHOR DETAILS
Show more
Product Code: FB 2759

List of Tables

  • TABLE 1 INCLUSIONS AND EXCLUSIONS
  • TABLE 2 USD EXCHANGE RATES, 2021-2025
  • TABLE 3 HEALTH BENEFITS ASSOCIATED WITH OMEGA-3 CONSUMPTION
  • TABLE 4 UPCOMING ALTERNATIVE SOURCES FOR OMEGA-3 FATTY ACIDS
  • TABLE 5 KEY MOVES AND STRATEGIC FOCUS
  • TABLE 6 OMEGA-3 MARKET: PORTER'S FIVE FORCES ANALYSIS
  • TABLE 7 OMEGA-3 MARKET: SUPPLY CHAIN (ECOSYSTEM)
  • TABLE 8 AVERAGE SELLING PRICE (ASP) TREND, BY REGION, 2022-2025 (USD/TON)
  • TABLE 9 AVERAGE SELLING PRICE (ASP) TREND, BY SOURCE, 2022-2025 (USD/TON)
  • TABLE 10 TOP IMPORTERS OF OMEGA-3, 2022-2025 (USD)
  • TABLE 11 TOP EXPORTERS OF OMEGA-3, 2022-2025 (USD)
  • TABLE 12 OMEGA-3 MARKET: LIST OF KEY CONFERENCES AND EVENTS, 2026-2027
  • TABLE 13 PATENTS PERTAINING TO OMEGA 3 MARKET, 2021-2026
  • TABLE 14 TOP USE CASES AND MARKET POTENTIAL
  • TABLE 15 BEST PRACTICES: COMPANIES IMPLEMENTING USE CASES
  • TABLE 16 OMEGA 3 MARKET: CASE STUDIES RELATED TO GEN AI IMPLEMENTATION
  • TABLE 17 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS
  • TABLE 18 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 19 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 20 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 21 SOUTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 22 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 23 INTERNATIONAL: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 24 INDUSTRY STANDARDS IN OMEGA-3 MARKET
  • TABLE 25 LABELING REQUIREMENTS AND CLAIMS IN OMEGA-3 MARKET
  • TABLE 26 CERTIFICATIONS, LABELING, AND ECO-STANDARDS IN OMEGA-3 MARKET
  • TABLE 27 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR KEY PRODUCT TYPES
  • TABLE 28 KEY BUYING CRITERIA FOR TOP PRODUCT TYPES
  • TABLE 29 UNMET NEEDS IN OMEGA MARKET, BY APPLICATION INDUSTRIES ACROSS THE SUPPLY CHAIN
  • TABLE 30 COST DYNAMICS IN OMEGA 3 MARKET
  • TABLE 31 OMEGA-3 MARKET, BY TYPE, 2022-2025 (USD MILLION)
  • TABLE 32 OMEGA-3 MARKET, BY TYPE, 2026-2031 (USD MILLION)
  • TABLE 33 FOOD SOURCES FOR DHA (GRAMS PER SERVING)
  • TABLE 34 DOCOSAHEXAENOIC ACID MARKET, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 35 DOCOSAHEXAENOIC ACID MARKET, BY REGION, 2026-2031 (USD MILLION)
  • TABLE 36 FOOD SOURCES FOR EPA (GRAMS PER SERVING)
  • TABLE 37 EICOSAPENTAENOIC ACID MARKET, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 38 EICOSAPENTAENOIC ACID MARKET, BY REGION, 2026-2031 (USD MILLION)
  • TABLE 39 FOOD SOURCES FOR ALA (GRAMS PER SERVING)
  • TABLE 40 ALPHA-LINOLENIC ACID MARKET, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 41 ALPHA-LINOLENIC ACID MARKET, BY REGION, 2026-2031 (USD MILLION)
  • TABLE 42 OMEGA-3 MARKET, BY SOURCE, 2022-2025 (USD MILLION)
  • TABLE 43 OMEGA-3 MARKET, BY SOURCE, 2026-2031 (USD MILLION)
  • TABLE 44 OMEGA-3 MARKET, BY SOURCE, 2022-2025 (KILOTONS)
  • TABLE 45 OMEGA-3 MARKET, BY SOURCE, 2026-2031 (KILOTONS)
  • TABLE 46 MARINE-BASED FOOD SOURCES CONTAINING OMEGA-3 ACIDS
  • TABLE 47 OMEGA-3 MARKET FROM MARINE SOURCES, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 48 OMEGA-3 MARKET FROM MARINE SOURCES, BY REGION, 2026-2031 (USD MILLION)
  • TABLE 49 OMEGA-3 MARKET FROM MARINE SOURCE, BY REGION, 2022-2025 (KILOTONS)
  • TABLE 50 OMEGA-3 MARKET FROM MARINE SOURCES, BY REGION, 2026-2031 (KILOTONS)
  • TABLE 51 OMEGA-3 MARKET FROM MARINE SOURCES, BY SOURCE TYPE, 2022-2025 (USD MILLION)
  • TABLE 52 OMEGA-3 MARKET FROM MARINE SOURCES, BY SOURCE TYPE, 2026-2031 (USD MILLION)
  • TABLE 53 OMEGA-3 MARKET FROM FISH, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 54 OMEGA-3 MARKET FROM FISH, BY REGION, 2026-2031 (USD MILLION)
  • TABLE 55 OMEGA-3 MARKET FROM ALGAE, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 56 OMEGA-3 MARKET FROM ALGAE, BY REGION, 2026-2031 (USD MILLION)
  • TABLE 57 OMEGA-3 MARKET FROM KRILL, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 58 OMEGA-3 MARKET FROM KRILL, BY REGION, 2026-2031 (USD MILLION)
  • TABLE 59 OMEGA-3 MARKET FROM OTHER MARINE SOURCES, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 60 OMEGA-3 MARKET FROM OTHER MARINE SOURCES, BY REGION, 2026-2031 (USD MILLION)
  • TABLE 61 OMEGA-3 MARKET FROM PLANT SOURCES, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 62 OMEGA-3 MARKET FROM PLANT SOURCES, BY REGION, 2026-2031 (USD MILLION)
  • TABLE 63 OMEGA-3 MARKET FROM PLANT SOURCES, BY REGION, 2022-2025 (KILOTONS)
  • TABLE 64 OMEGA-3 MARKET FROM PLANT SOURCES, BY REGION, 2026-2031 (KILOTONS)
  • TABLE 65 OMEGA-3 MARKET FROM PLANT SOURCES, BY SOURCE TYPE, 2022-2025 (USD MILLION)
  • TABLE 66 OMEGA-3 MARKET FROM PLANT SOURCES, BY SOURCE TYPE, 2026-2031 (USD MILLION)
  • TABLE 67 OMEGA-3 MARKET FROM NUTS & SEEDS, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 68 OMEGA-3 MARKET FROM NUTS & SEEDS, BY REGION, 2026-2031 (USD MILLION)
  • TABLE 69 OMEGA-3 MARKET FROM VEGETABLE OILS, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 70 OMEGA-3 MARKET FROM VEGETABLE OILS, BY REGION, 2026-2031 (USD MILLION)
  • TABLE 71 OMEGA-3 MARKET, BY APPLICATION, 2022-2025 (USD MILLION)
  • TABLE 72 OMEGA-3 MARKET, BY APPLICATION, 2026-2031 (USD MILLION)
  • TABLE 73 OMEGA-3 MARKET IN DIETARY SUPPLEMENTS, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 74 OMEGA-3 MARKET IN DIETARY SUPPLEMENTS, BY REGION, 2026-2031 (USD MILLION)
  • TABLE 75 OMEGA-3 MARKET IN FUNCTIONAL FOODS & BEVERAGES, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 76 OMEGA-3 MARKET IN FUNCTIONAL FOODS & BEVERAGES, BY REGION, 2026-2031 (USD MILLION)
  • TABLE 77 OMEGA-3 MARKET IN PHARMACEUTICALS, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 78 OMEGA-3 MARKET IN PHARMACEUTICALS, BY REGION, 2026-2031 (USD MILLION)
  • TABLE 79 OMEGA-3 MARKET IN INFANT FORMULAS, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 80 OMEGA-3 MARKET IN INFANT FORMULAS, BY REGION, 2026-2031 (USD MILLION)
  • TABLE 81 OMEGA-3 MARKET IN PET FOOD & FEED, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 82 OMEGA-3 MARKET IN PET FOOD & FEED, BY REGION, 2026-2031 (USD MILLION)
  • TABLE 83 OMEGA-3 MARKET, BY FORM, 2022-2025 (USD MILLION)
  • TABLE 84 OMEGA-3 MARKET, BY FORM, 2026-2031 (USD MILLION)
  • TABLE 85 DRY OMEGA-3 MARKET, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 86 DRY OMEGA-3 MARKET, BY REGION, 2026-2031 (USD MILLION)
  • TABLE 87 LIQUID OMEGA-3 MARKET, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 88 LIQUID OMEGA-3 MARKET, BY REGION, 2026-2031 (USD MILLION)
  • TABLE 89 OMEGA-3 MARKET, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 90 OMEGA-3 MARKET, BY REGION, 2026-2031 (USD MILLION)
  • TABLE 91 OMEGA-3 MARKET, BY REGION, 2022-2025 (KILOTONS)
  • TABLE 92 OMEGA-3 MARKET, BY REGION, 2026-2031 (KILOTONS)
  • TABLE 93 NORTH AMERICA: OMEGA-3 MARKET, BY COUNTRY, 2022-2025 (USD MILLION)
  • TABLE 94 NORTH AMERICA: OMEGA-3 MARKET, BY COUNTRY, 2026-2031 (USD MILLION)
  • TABLE 95 NORTH AMERICA: OMEGA-3 MARKET, BY TYPE, 2022-2025 (USD MILLION)
  • TABLE 96 NORTH AMERICA: OMEGA-3 MARKET, BY TYPE, 2026-2031 (USD MILLION)
  • TABLE 97 NORTH AMERICA: OMEGA-3 MARKET, BY APPLICATION, 2022-2025 (USD MILLION)
  • TABLE 98 NORTH AMERICA: OMEGA-3 MARKET, BY APPLICATION, 2026-2031 (USD MILLION)
  • TABLE 99 NORTH AMERICA: OMEGA-3 MARKET, BY SOURCE, 2022-2025 (USD MILLION)
  • TABLE 100 NORTH AMERICA: OMEGA-3 MARKET, BY SOURCE, 2026-2031 (USD MILLION)
  • TABLE 101 NORTH AMERICA: OMEGA-3 MARKET, BY SOURCE, 2022-2025 (KILOTONS)
  • TABLE 102 NORTH AMERICA: OMEGA-3 MARKET, BY SOURCE, 2026-2031 (KILOTONS)
  • TABLE 103 NORTH AMERICA: MARINE OMEGA-3 MARKET, BY SOURCE TYPE, 2022-2025 (USD MILLION)
  • TABLE 104 NORTH AMERICA: MARINE OMEGA-3 MARKET, BY SOURCE TYPE, 2026-2031 (USD MILLION)
  • TABLE 105 NORTH AMERICA: PLANT OMEGA-3 MARKET, BY SOURCE TYPE, 2022-2025 (USD MILLION)
  • TABLE 106 NORTH AMERICA: PLANT OMEGA-3 MARKET, BY SOURCE TYPE, 2026-2031 (USD MILLION)
  • TABLE 107 US: OMEGA-3 MARKET, BY TYPE, 2022-2025 (USD MILLION)
  • TABLE 108 US: OMEGA-3 MARKET, BY TYPE, 2026-2031 (USD MILLION)
  • TABLE 109 US: OMEGA-3 MARKET, BY SOURCE, 2022-2025 (USD MILLION)
  • TABLE 110 US: OMEGA-3 MARKET, BY SOURCE, 2026-2031 (USD MILLION)
  • TABLE 111 CANADA: OMEGA-3 MARKET, BY TYPE, 2022-2025 (USD MILLION)
  • TABLE 112 CANADA: OMEGA-3 MARKET, BY TYPE, 2026-2031 (USD MILLION)
  • TABLE 113 CANADA: OMEGA-3 MARKET, BY SOURCE, 2022-2025 (USD MILLION)
  • TABLE 114 CANADA: OMEGA-3 MARKET, BY SOURCE, 2026-2031 (USD MILLION)
  • TABLE 115 MEXICO: OMEGA-3 MARKET, BY TYPE, 2022-2025 (USD MILLION)
  • TABLE 116 MEXICO: OMEGA-3 MARKET, BY TYPE, 2026-2031 (USD MILLION)
  • TABLE 117 MEXICO: OMEGA-3 MARKET, BY SOURCE, 2022-2025 (USD MILLION)
  • TABLE 118 MEXICO: OMEGA-3 MARKET, BY SOURCE, 2026-2031 (USD MILLION)
  • TABLE 119 EUROPE: OMEGA-3 MARKET, BY COUNTRY, 2022-2025 (USD MILLION)
  • TABLE 120 EUROPE: OMEGA-3 MARKET, BY COUNTRY, 2026-2031 (USD MILLION)
  • TABLE 121 EUROPE: OMEGA-3 MARKET, BY TYPE, 2022-2025 (USD MILLION)
  • TABLE 122 EUROPE: OMEGA-3 MARKET, BY TYPE, 2026-2031 (USD MILLION)
  • TABLE 123 EUROPE: OMEGA-3 MARKET, BY APPLICATION, 2022-2025 (USD MILLION)
  • TABLE 124 EUROPE: OMEGA-3 MARKET, BY APPLICATION, 2026-2031 (USD MILLION)
  • TABLE 125 EUROPE: OMEGA-3 MARKET, BY SOURCE, 2022-2025 (USD MILLION)
  • TABLE 126 EUROPE: OMEGA-3 MARKET, BY SOURCE, 2026-2031 (USD MILLION)
  • TABLE 127 EUROPE: OMEGA-3 MARKET, BY SOURCE, 2022-2025 (KILOTONS)
  • TABLE 128 EUROPE: OMEGA-3 MARKET, BY SOURCE, 2026-2031 (KILOTONS)
  • TABLE 129 EUROPE: MARINE OMEGA-3 MARKET, BY SOURCE TYPE, 2022-2025 (USD MILLION)
  • TABLE 130 EUROPE: MARINE OMEGA-3 MARKET, BY SOURCE TYPE, 2026-2031 (USD MILLION)
  • TABLE 131 EUROPE: PLANT OMEGA-3 MARKET, BY SOURCE TYPE, 2022-2025 (USD MILLION)
  • TABLE 132 EUROPE: PLANT OMEGA-3 MARKET, BY SOURCE TYPE, 2026-2031 (USD MILLION)
  • TABLE 133 GERMANY: OMEGA-3 MARKET, BY TYPE, 2022-2025 (USD MILLION)
  • TABLE 134 GERMANY: OMEGA-3 MARKET, BY TYPE, 2026-2031 (USD MILLION)
  • TABLE 135 GERMANY: OMEGA-3 MARKET, BY SOURCE, 2022-2025 (USD MILLION)
  • TABLE 136 GERMANY: OMEGA-3 MARKET, BY SOURCE, 2026-2031 (USD MILLION)
  • TABLE 137 UK: OMEGA-3 MARKET, BY TYPE, 2022-2025 (USD MILLION)
  • TABLE 138 UK: OMEGA-3 MARKET, BY TYPE, 2026-2031 (USD MILLION)
  • TABLE 139 UK: OMEGA-3 MARKET, BY SOURCE, 2022-2025 (USD MILLION)
  • TABLE 140 UK: OMEGA-3 MARKET, BY SOURCE, 2026-2031 (USD MILLION)
  • TABLE 141 FRANCE: OMEGA-3 MARKET, BY TYPE, 2022-2025 (USD MILLION)
  • TABLE 142 FRANCE: OMEGA-3 MARKET, BY TYPE, 2026-2031 (USD MILLION)
  • TABLE 143 FRANCE: OMEGA-3 MARKET, BY SOURCE, 2022-2025 (USD MILLION)
  • TABLE 144 FRANCE: OMEGA-3 MARKET, BY SOURCE, 2026-2031 (USD MILLION)
  • TABLE 145 NORWAY: OMEGA-3 MARKET, BY TYPE, 2022-2025 (USD MILLION)
  • TABLE 146 NORWAY: OMEGA-3 MARKET, BY TYPE, 2026-2031 (USD MILLION)
  • TABLE 147 NORWAY: OMEGA-3 MARKET, BY SOURCE, 2022-2025 (USD MILLION)
  • TABLE 148 NORWAY: OMEGA-3 MARKET, BY SOURCE, 2026-2031 (USD MILLION)
  • TABLE 149 ITALY: OMEGA-3 MARKET, BY TYPE, 2022-2025 (USD MILLION)
  • TABLE 150 ITALY: OMEGA-3 MARKET, BY TYPE, 2026-2031 (USD MILLION)
  • TABLE 151 ITALY: OMEGA-3 MARKET, BY SOURCE, 2022-2025 (USD MILLION)
  • TABLE 152 ITALY: OMEGA-3 MARKET, BY SOURCE, 2026-2031 (USD MILLION)
  • TABLE 153 SPAIN: OMEGA-3 MARKET, BY TYPE, 2022-2025 (USD MILLION)
  • TABLE 154 SPAIN: OMEGA-3 MARKET, BY TYPE, 2026-2031 (USD MILLION)
  • TABLE 155 SPAIN: OMEGA-3 MARKET, BY SOURCE, 2022-2025 (USD MILLION)
  • TABLE 156 SPAIN: OMEGA-3 MARKET, BY SOURCE, 2026-2031 (USD MILLION)
  • TABLE 157 NETHERLANDS: OMEGA-3 MARKET, BY TYPE, 2022-2025 (USD MILLION)
  • TABLE 158 NETHERLANDS: OMEGA-3 MARKET, BY TYPE, 2026-2031 (USD MILLION)
  • TABLE 159 NETHERLANDS: OMEGA-3 MARKET, BY SOURCE, 2022-2025 (USD MILLION)
  • TABLE 160 NETHERLANDS: OMEGA-3 MARKET, BY SOURCE, 2026-2031 (USD MILLION)
  • TABLE 161 REST OF EUROPE: OMEGA-3 MARKET, BY TYPE, 2022-2025 (USD MILLION)
  • TABLE 162 REST OF EUROPE: OMEGA-3 MARKET, BY TYPE, 2026-2031 (USD MILLION)
  • TABLE 163 REST OF EUROPE: OMEGA-3 MARKET, BY SOURCE, 2022-2025 (USD MILLION)
  • TABLE 164 REST OF EUROPE: OMEGA-3 MARKET, BY SOURCE, 2026-2031 (USD MILLION)
  • TABLE 165 ASIA PACIFIC: OMEGA-3 MARKET, BY COUNTRY, 2022-2025 (USD MILLION)
  • TABLE 166 ASIA PACIFIC: OMEGA-3 MARKET, BY COUNTRY, 2026-2031 (USD MILLION)
  • TABLE 167 ASIA PACIFIC: OMEGA-3 MARKET, BY TYPE, 2022-2025 (USD MILLION)
  • TABLE 168 ASIA PACIFIC: OMEGA-3 MARKET, BY TYPE, 2026-2031 (USD MILLION)
  • TABLE 169 ASIA PACIFIC: OMEGA-3 MARKET, BY APPLICATION, 2022-2025 (USD MILLION)
  • TABLE 170 ASIA PACIFIC: OMEGA-3 MARKET, BY APPLICATION, 2026-2031 (USD MILLION)
  • TABLE 171 ASIA PACIFIC: OMEGA-3 MARKET, BY SOURCE, 2022-2025 (USD MILLION)
  • TABLE 172 ASIA PACIFIC: OMEGA-3 MARKET, BY SOURCE, 2026-2031 (USD MILLION)
  • TABLE 173 ASIA PACIFIC: OMEGA-3 MARKET, BY SOURCE, 2022-2025 (KILOTONS)
  • TABLE 174 ASIA PACIFIC: OMEGA-3 MARKET, BY SOURCE, 2026-2031 (KILOTONS)
  • TABLE 175 ASIA PACIFIC: MARINE OMEGA-3 MARKET, BY SOURCE TYPE, 2022-2025 (USD MILLION)
  • TABLE 176 ASIA PACIFIC: MARINE OMEGA-3 MARKET, BY SOURCE TYPE, 2026-2031 (USD MILLION)
  • TABLE 177 ASIA PACIFIC: PLANT OMEGA-3 MARKET, BY SOURCE TYPE, 2022-2025 (USD MILLION)
  • TABLE 178 ASIA PACIFIC: PLANT OMEGA-3 MARKET, BY SOURCE TYPE, 2026-2031 (USD MILLION)
  • TABLE 179 CHINA: OMEGA-3 MARKET, BY TYPE, 2022-2025 (USD MILLION)
  • TABLE 180 CHINA: OMEGA-3 MARKET, BY TYPE, 2026-2031 (USD MILLION)
  • TABLE 181 CHINA: OMEGA-3 MARKET, BY SOURCE, 2022-2025 (USD MILLION)
  • TABLE 182 CHINA: OMEGA-3 MARKET, BY SOURCE, 2026-2031 (USD MILLION)
  • TABLE 183 INDIA: OMEGA-3 MARKET, BY TYPE, 2022-2025 (USD MILLION)
  • TABLE 184 INDIA: OMEGA-3 MARKET, BY TYPE, 2026-2031 (USD MILLION)
  • TABLE 185 INDIA: OMEGA-3 MARKET, BY SOURCE, 2022-2025 (USD MILLION)
  • TABLE 186 INDIA: OMEGA-3 MARKET, BY SOURCE, 2026-2031 (USD MILLION)
  • TABLE 187 JAPAN: OMEGA-3 MARKET, BY TYPE, 2022-2025 (USD MILLION)
  • TABLE 188 JAPAN: OMEGA-3 MARKET, BY TYPE, 2026-2031 (USD MILLION)
  • TABLE 189 JAPAN: OMEGA-3 MARKET, BY SOURCE, 2022-2025 (USD MILLION)
  • TABLE 190 JAPAN: OMEGA-3 MARKET, BY SOURCE, 2026-2031 (USD MILLION)
  • TABLE 191 AUSTRALIA & NEW ZEALAND: OMEGA-3 MARKET, BY TYPE, 2022-2025 (USD MILLION)
  • TABLE 192 AUSTRALIA & NEW ZEALAND: OMEGA-3 MARKET, BY TYPE, 2026-2031 (USD MILLION)
  • TABLE 193 AUSTRALIA & NEW ZEALAND: OMEGA-3 MARKET, BY SOURCE, 2022-2025 (USD MILLION)
  • TABLE 194 AUSTRALIA & NEW ZEALAND: OMEGA-3 MARKET, BY SOURCE, 2026-2031 (USD MILLION)
  • TABLE 195 REST OF ASIA PACIFIC: OMEGA-3 MARKET, BY TYPE, 2022-2025 (USD MILLION)
  • TABLE 196 REST OF ASIA PACIFIC: OMEGA-3 MARKET, BY TYPE, 2026-2031 (USD MILLION)
  • TABLE 197 REST OF ASIA PACIFIC: OMEGA-3 MARKET, BY SOURCE, 2022-2025 (USD MILLION)
  • TABLE 198 REST OF ASIA PACIFIC: OMEGA-3 MARKET, BY SOURCE, 2026-2031 (USD MILLION)
  • TABLE 199 SOUTH AMERICA: OMEGA-3 MARKET, BY COUNTRY, 2022-2025 (USD MILLION)
  • TABLE 200 SOUTH AMERICA: OMEGA-3 MARKET, BY COUNTRY, 2026-2031 (USD MILLION)
  • TABLE 201 SOUTH AMERICA: OMEGA-3 MARKET, BY TYPE, 2022-2025 (USD MILLION)
  • TABLE 202 SOUTH AMERICA: OMEGA-3 MARKET, BY TYPE, 2026-2031 (USD MILLION)
  • TABLE 203 SOUTH AMERICA: OMEGA-3 MARKET, BY APPLICATION, 2022-2025 (USD MILLION)
  • TABLE 204 SOUTH AMERICA: OMEGA-3 MARKET, BY APPLICATION, 2026-2031 (USD MILLION)
  • TABLE 205 SOUTH AMERICA: OMEGA-3 MARKET, BY SOURCE, 2022-2025 (USD MILLION)
  • TABLE 206 SOUTH AMERICA: OMEGA-3 MARKET, BY SOURCE, 2026-2031 (USD MILLION)
  • TABLE 207 SOUTH AMERICA: OMEGA-3 MARKET, BY SOURCE, 2022-2025 (KILOTONS)
  • TABLE 208 SOUTH AMERICA: OMEGA-3 MARKET, BY SOURCE, 2026-2031 (KILOTONS)
  • TABLE 209 SOUTH AMERICA: MARINE OMEGA-3 MARKET, BY SOURCE TYPE, 2022-2025 (USD MILLION)
  • TABLE 210 SOUTH AMERICA: MARINE OMEGA-3 MARKET, BY SOURCE TYPE, 2026-2031 (USD MILLION)
  • TABLE 211 SOUTH AMERICA: PLANT OMEGA-3 MARKET, BY SOURCE TYPE, 2022-2025 (USD MILLION)
  • TABLE 212 SOUTH AMERICA: PLANT OMEGA-3 MARKET, BY SOURCE TYPE, 2026-2031 (USD MILLION)
  • TABLE 213 BRAZIL: OMEGA-3 MARKET, BY TYPE, 2022-2025 (USD MILLION)
  • TABLE 214 BRAZIL: OMEGA-3 MARKET, BY TYPE, 2026-2031 (USD MILLION)
  • TABLE 215 BRAZIL: OMEGA-3 MARKET, BY SOURCE, 2022-2025 (USD MILLION)
  • TABLE 216 BRAZIL: OMEGA-3 MARKET, BY SOURCE, 2026-2031 (USD MILLION)
  • TABLE 217 ARGENTINA: OMEGA-3 MARKET, BY TYPE, 2022-2025 (USD MILLION)
  • TABLE 218 ARGENTINA: OMEGA-3 MARKET, BY TYPE, 2026-2031 (USD MILLION)
  • TABLE 219 ARGENTINA: OMEGA-3 MARKET, BY SOURCE, 2022-2025 (USD MILLION)
  • TABLE 220 ARGENTINA: OMEGA-3 MARKET, BY SOURCE, 2026-2031 (USD MILLION)
  • TABLE 221 REST OF SOUTH AMERICA: OMEGA-3 MARKET, BY TYPE, 2022-2025 (USD MILLION)
  • TABLE 222 REST OF SOUTH AMERICA: OMEGA-3 MARKET, BY TYPE, 2026-2031 (USD MILLION)
  • TABLE 223 REST OF SOUTH AMERICA: OMEGA-3 MARKET, BY SOURCE, 2022-2025 (USD MILLION)
  • TABLE 224 REST OF SOUTH AMERICA: OMEGA-3 MARKET, BY SOURCE, 2026-2031 (USD MILLION)
  • TABLE 225 ROW: OMEGA-3 MARKET, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 226 ROW: OMEGA-3 MARKET, BY REGION, 2026-2031 (USD MILLION)
  • TABLE 227 ROW: OMEGA-3 MARKET, BY TYPE, 2022-2025 (USD MILLION)
  • TABLE 228 ROW: OMEGA-3 MARKET, BY TYPE, 2026-2031 (USD MILLION)
  • TABLE 229 ROW: OMEGA-3 MARKET, BY APPLICATION, 2022-2025 (USD MILLION)
  • TABLE 230 ROW: OMEGA-3 MARKET, BY APPLICATION, 2026-2031 (USD MILLION)
  • TABLE 231 ROW: OMEGA-3 MARKET, BY SOURCE, 2022-2025 (USD MILLION)
  • TABLE 232 ROW: OMEGA-3 MARKET, BY SOURCE, 2026-2031 (USD MILLION)
  • TABLE 233 ROW: OMEGA-3 MARKET, BY SOURCE, 2022-2025 (KILOTONS)
  • TABLE 234 ROW: OMEGA-3 MARKET, BY SOURCE, 2026-2031 (KILOTONS)
  • TABLE 235 ROW: MARINE OMEGA-3 MARKET, BY SOURCE TYPE, 2022-2025 (USD MILLION)
  • TABLE 236 ROW: MARINE OMEGA-3 MARKET, BY SOURCE TYPE, 2026-2031 (USD MILLION)
  • TABLE 237 ROW: PLANT OMEGA-3 MARKET, BY SOURCE TYPE, 2022-2025 (USD MILLION)
  • TABLE 238 ROW: PLANT OMEGA-3 MARKET, BY SOURCE TYPE, 2026-2031 (USD MILLION)
  • TABLE 239 AFRICA: OMEGA-3 MARKET, BY TYPE, 2022-2025 (USD MILLION)
  • TABLE 240 AFRICA: OMEGA-3 MARKET, BY TYPE, 2026-2031 (USD MILLION)
  • TABLE 241 AFRICA: OMEGA-3 MARKET, BY SOURCE, 2022-2025 (USD MILLION)
  • TABLE 242 AFRICA: OMEGA-3 MARKET, BY SOURCE, 2026-2031 (USD MILLION)
  • TABLE 243 MIDDLE EAST: OMEGA-3 MARKET, BY TYPE, 2022-2025 (USD MILLION)
  • TABLE 244 MIDDLE EAST: OMEGA-3 MARKET, BY TYPE, 2026-2031 (USD MILLION)
  • TABLE 245 MIDDLE EAST: OMEGA-3 MARKET, BY SOURCE, 2022-2025 (USD MILLION)
  • TABLE 246 MIDDLE EAST: OMEGA-3 MARKET, BY SOURCE, 2026-2031 (USD MILLION)
  • TABLE 247 OVERVIEW OF STRATEGIES ADOPTED BY KEY OMEGA-3 MARKET PLAYERS
  • TABLE 248 OMEGA-3 MARKET: MARKET SHARE ANALYSIS, 2025
  • TABLE 249 OMEGA-3 MARKET: REGIONAL FOOTPRINT, 2024
  • TABLE 250 OMEGA-3 MARKET: SOURCE FOOTPRINT, 2024
  • TABLE 251 OMEGA-3 MARKET: TYPE FOOTPRINT, 2024
  • TABLE 252 OMEGA-3 MARKET: APPLICATION FOOTPRINT, 2024
  • TABLE 253 OMEGA-3 MARKET: DETAILED LIST OF KEY STARTUPS/SMES
  • TABLE 254 OMEGA-3 MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES
  • TABLE 255 OMEGA-3 MARKET: PRODUCT LAUNCHES, JUNE 2022-JULY 2026
  • TABLE 256 OMEGA-3 MARKET: DEALS, DECEMBER 2022-JULY 2026
  • TABLE 257 OMEGA-3 MARKET: EXPANSIONS, FEBRUARY 2020-JULY 2026
  • TABLE 258 DSM-FIRMENICH: COMPANY OVERVIEW
  • TABLE 259 DSM-FIRMENICH: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 260 DSM-FIRMENICH: PRODUCT LAUNCHES AND ENHANCEMENTS
  • TABLE 261 CARGILL, INCORPORATED: COMPANY OVERVIEW
  • TABLE 262 CARGILL, INCORPORATED: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 263 CARGILL, INCORPORATED: DEALS
  • TABLE 264 BASF SE: COMPANY OVERVIEW
  • TABLE 265 BASF SE: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 266 BASF SE: DEALS
  • TABLE 267 ADM: COMPANY OVERVIEW
  • TABLE 268 ADM: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 269 KERRY GROUP PLC: COMPANY OVERVIEW
  • TABLE 270 KERRY GROUP PLC: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 271 KERRY GROUP PLC: DEALS
  • TABLE 272 CORBION: COMPANY OVERVIEW
  • TABLE 273 CORBION: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 274 CORBION: PRODUCT LAUNCHES AND ENHANCEMENTS
  • TABLE 275 CORBION: OTHER DEVELOPMENTS
  • TABLE 276 KD PHARMA GROUP SA: COMPANY OVERVIEW
  • TABLE 277 KD PHARMA GROUP SA: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 278 KD PHARMA GROUP SA: DEALS
  • TABLE 279 KD PHARMA GROUP SA: EXPANSIONS
  • TABLE 280 AKER BIOMARINE: COMPANY OVERVIEW
  • TABLE 281 AKER BIOMARINE: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 282 AKER BIOMARINE: PRODUCT LAUNCHES AND ENHANCEMENTS
  • TABLE 283 AKER BIOMARINE: EXPANSIONS
  • TABLE 284 AKER BIOMARINE: DEALS
  • TABLE 285 AKER BIOMARINE: OTHER DEVELOPMENTS
  • TABLE 286 CRODA INTERNATIONAL PLC: COMPANY OVERVIEW
  • TABLE 287 CRODA INTERNATIONAL PLC: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 288 EVONIK INDUSTRIES AG: COMPANY OVERVIEW
  • TABLE 289 EVONIK INDUSTRIES AG: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 290 EVONIK INDUSTRIES AG: DEALS
  • TABLE 291 PELAGIA: COMPANY OVERVIEW
  • TABLE 292 PELAGIA: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 293 PELAGIA: PRODUCT LAUNCHES AND ENHANCEMENTS
  • TABLE 294 PELAGIA AS: OTHER DEVELOPMENTS
  • TABLE 295 GC RIEBER: COMPANY OVERVIEW
  • TABLE 296 GC RIEBER: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 297 GC RIEBER: PRODUCT LAUNCHES AND ENHANCEMENTS
  • TABLE 298 GC RIEBER: EXPANSIONS
  • TABLE 299 COOKE AQUACULTURE INC.: COMPANY OVERVIEW
  • TABLE 300 COOKE AQUACULTURE INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 301 COOKE AQUACULTURE INC.: DEALS
  • TABLE 302 ALGISYS BIOSCIENCES, INC.: COMPANY OVERVIEW
  • TABLE 303 ALGISYS BIOSCIENCES, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 304 ALGISYS BIOSCIENCES, INC.: OTHER DEVELOPMENTS
  • TABLE 305 POLARIS: COMPANY OVERVIEW
  • TABLE 306 POLARIS: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 307 POLARIS: PRODUCT LAUNCHES AND ENHANCEMENTS
  • TABLE 308 POLARIS: OTHER DEVELOPMENTS
  • TABLE 309 BTSA: COMPANY OVERVIEW
  • TABLE 310 BTSA: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 311 NOVOSANA EUROPE B.V.: COMPANY OVERVIEW
  • TABLE 312 NOVOSANA EUROPE B.V.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 313 GOLDEN OMEGA: COMPANY OVERVIEW
  • TABLE 314 GOLDEN OMEGA: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 315 GOLDEN OMEGA: DEALS
  • TABLE 316 KINOMEGA BIOPHARM INC.: COMPANY OVERVIEW
  • TABLE 317 KINOMEGA BIOPHARM INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 318 RIMFROST AS: COMPANY OVERVIEW
  • TABLE 319 RIMFROST AS: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 320 RIMFROST AS: DEALS
  • TABLE 321 MARKETS ADJACENT TO OMEGA-3 MARKET
  • TABLE 322 FUNCTIONAL FOOD INGREDIENTS MARKET, BY SOURCE, 2019-2023 (USD MILLION)
  • TABLE 323 FUNCTIONAL FOOD INGREDIENTS MARKET, BY SOURCE, 2024-2029 (USD MILLION)
  • TABLE 324 MARINE COLLAGEN MARKET, BY FORM, 2022-2025 (USD MILLION)
  • TABLE 325 MARINE COLLAGEN MARKET, BY FORM, 2026-2031 (USD MILLION)

List of Figures

  • FIGURE 1 OMEGA-3 MARKETS COVERED
  • FIGURE 2 STUDY YEARS CONSIDERED
  • FIGURE 3 MARKET SCENARIO
  • FIGURE 4 OMEGA-3 MARKET, 2022-2031
  • FIGURE 5 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN OMEGA-3 MARKET, JULY 2021-MAY 2026
  • FIGURE 6 DISRUPTIONS INFLUENCING GROWTH OF OMEGA-3 MARKET
  • FIGURE 7 OMEGA-3 MARKET: HIGH-GROWTH SEGMENTS, 2026-2031
  • FIGURE 8 ASIA PACIFIC TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
  • FIGURE 9 INCREASING DEMAND FOR OMEGA-3 ACROSS FUNCTIONAL FOODS AND DIETARY SUPPLEMENTS TO SUPPORT MARKET GROWTH
  • FIGURE 10 TYPE SEGMENT DOCOSAHEXAENOIC ACID (DHA) AND NORTH AMERICA REGION TO ACCOUNT FOR LARGEST MARKET SHARES IN 2026
  • FIGURE 11 OMEGA-3 DOCOSAHEXAENOIC ACID (DHA) TYPE SEGMENT TO LEAD MARKET IN 2026
  • FIGURE 12 MARINE SEGMENT TO ACCOUNT FOR LARGEST MARKET SHARE IN 2026
  • FIGURE 13 BY FORM SEGMENT DRY FORM SEGMENT TO DOMINATE MARKET IN 2026
  • FIGURE 14 DIETARY SUPPLEMENTS APPLICATION SEGMENT TO DOMINATE MARKET IN 2026
  • FIGURE 15 US TO ACCOUNT FOR LARGEST MARKET SHARE IN 2026
  • FIGURE 16 OMEGA-3 MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 17 RECOMMENDED EPA LEVELS IN DOG FOOD (MG)
  • FIGURE 18 MICROALGAE PROCESSING FOR OMEGA-3
  • FIGURE 19 OMEGA-3 MARKET: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 20 PREVENTIVE HEALTHCARE EXPENDITURE AS PERCENTAGE OF GDP, BY COUNTRY, 2023
  • FIGURE 21 GLOBAL POPULATION AGED 65 AND ABOVE (% OF TOTAL POPULATION), 2014-2025
  • FIGURE 22 OMEGA-3 MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 23 OMEGA-3 MARKET ECOSYSTEM MAP
  • FIGURE 24 AVERAGE SELLING PRICE OF OMEGA-3 FINISHED PRODUCTS, BY PRODUCT TYPE, 2025 (USD)
  • FIGURE 25 AVERAGE SELLING PRICE (ASP) TREND, BY REGION, 2022-2025 (USD/TON)
  • FIGURE 26 IMPORT OF HS CODE 1504, BY KEY COUNTRY, 2022-2025 (USD)
  • FIGURE 27 EXPORT OF HS CODE 1504, BY KEY COUNTRY, 2022-2025 (USD)
  • FIGURE 28 TRENDS/DISRUPTIONS INFLUENCING CUSTOMERS' BUSINESSES
  • FIGURE 29 INVESTMENT AND FUNDING SCENARIO
  • FIGURE 30 NUMBER OF PATENTS GRANTED BETWEEN 2016 AND 2026
  • FIGURE 31 FUTURE APPLICATIONS
  • FIGURE 32 OMEGA-3 MARKET DECISION-MAKING FACTORS
  • FIGURE 33 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR KEY PRODUCT TYPES
  • FIGURE 34 KEY BUYING CRITERIA FOR TOP PRODUCT TYPES
  • FIGURE 35 ADOPTION BARRIERS AND INTERNAL CHALLENGES
  • FIGURE 36 OMEGA-3 MARKET, BY TYPE, 2026 VS. 2031 (USD MILLION)
  • FIGURE 37 OMEGA-3 MARKET, BY SOURCE, 2026 VS. 2031 (USD MILLION)
  • FIGURE 38 OMEGA-3 MARKET, BY APPLICATION, 2026 VS. 2031 (USD MILLION)
  • FIGURE 39 OMEGA-3 MARKET, BY FORM, 2026 VS. 2031 (USD MILLION)
  • FIGURE 40 INDIA TO RECORD HIGHEST GROWTH RATE IN THE OMEGA-3 MARKET
  • FIGURE 41 NORTH AMERICA: REGIONAL SNAPSHOT
  • FIGURE 42 ASIA PACIFIC: REGIONAL SNAPSHOT
  • FIGURE 43 REVENUE ANALYSIS OF KEY PLAYERS, 2023-2025 (USD BILLION)
  • FIGURE 44 OMEGA-3 MARKET SHARE ANALYSIS, 2025
  • FIGURE 45 COMPANY VALUATION FOR MAJOR PLAYERS IN OMEGA-3 MARKET
  • FIGURE 46 EV/EBITDA OF MAJOR PLAYERS
  • FIGURE 47 OMEGA-3 MARKET: BRAND/PRODUCT COMPARISON
  • FIGURE 48 OMEGA-3 MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025
  • FIGURE 49 OMEGA-3 MARKET: COMPANY FOOTPRINT, 2024
  • FIGURE 50 OMEGA-3 MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
  • FIGURE 51 DSM-FIRMENICH: COMPANY SNAPSHOT
  • FIGURE 52 CARGILL, INCORPORATED: COMPANY SNAPSHOT
  • FIGURE 53 BASF SE: COMPANY SNAPSHOT
  • FIGURE 54 ADM: COMPANY SNAPSHOT
  • FIGURE 55 KERRY GROUP PLC: COMPANY SNAPSHOT
  • FIGURE 56 CORBION: COMPANY SNAPSHOT
  • FIGURE 57 KD PHARMA GROUP SA: COMPANY SNAPSHOT
  • FIGURE 58 AKER BIOMARINE: COMPANY SNAPSHOT
  • FIGURE 59 CRODA INTERNATIONAL PLC: COMPANY SNAPSHOT
  • FIGURE 60 EVONIK INDUSTRIES AG: COMPANY SNAPSHOT
  • FIGURE 61 PELAGIA: COMPANY SNAPSHOT
  • FIGURE 62 GC RIEBER: COMPANY SNAPSHOT
  • FIGURE 63 OMEGA-3 MARKET: RESEARCH DESIGN
  • FIGURE 64 BREAKDOWN OF PRIMARY INTERVIEWS, BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 65 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • FIGURE 66 SUPPLY-SIDE ANALYSIS: SOURCES OF INFORMATION AT EVERY STEP
  • FIGURE 67 OMEGA-3 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
  • FIGURE 68 DATA TRIANGULATION
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!